GIP and type 2 diabetes mellitus: As already alluded to, infusions of GLP-1 in supraphysiological amounts or administration of GLP-1 receptor agonists are capable of inducing insulin secretion and appetite reduction also in obese patients with T2DM, whereas infusions of GIP are remarkably ineffective, regardless of infusion rate (28).